Reply to the Editor—Fear does not avoid the danger

Published:August 18, 2020DOI:
      We thank Drs Clementy, Bisson, and Fauchier for their interest in our article and for sharing their experiences of the implantable cardioverter-defibrillator (ICD) programming.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Moss A.J.
        • Schuger C.
        • Beck C.A.
        • et al.
        Reduction in inappropriate therapy and mortality through ICD programming.
        N Engl J Med. 2012; 367: 2275-2283
        • Clementy N.
        • Challal F.
        • Marijon E.
        • et al.
        Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: results from a large multicenter controlled study.
        Heart Rhythm. 2017; 14: 211-217
        • Stiles M.K.
        • Fauchier L.
        • Morillo C.A.
        • Wilkoff B.L.
        2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
        Heart Rhythm. 2020; 17: e220-e228
        • Thogersen A.M.
        • Larsen J.M.
        • Johansen J.B.
        • Abedin M.
        • Swerdlow C.D.
        Failure to treat life-threatening ventricular tachyarrhythmias in contemporary implantable cardioverter-defibrillators: implications for strategic programming.
        Circ Arrhythm Electrophysiol. 2017; 10e005305

      Linked Article

      • To the Editor—Fear does not avoid the danger!
        Heart RhythmVol. 18Issue 1
        • Preview
          We have read with much attention the article by Ananwattanasuk et al,1 and their results are of the greatest importance. One key to success is the standardization of implantable cardioverter-defibrillator (ICD) programming, as previously shown in the EMPIRIC trial.2 In that perspective, the benefits of programming guidelines, even if partly based on expert consensus, are undeniable.3 One step further toward standardized programming may require to smooth the effects of the various algorithms of different manufacturers.
        • Full-Text
        • PDF